{"id":33126,"date":"2022-01-06T00:00:02","date_gmt":"2022-01-06T08:00:02","guid":{"rendered":"https:\/\/vermont.salk.edu\/?post_type=disclosure&p=33126"},"modified":"2022-01-11T08:19:24","modified_gmt":"2022-01-11T16:19:24","slug":"salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes","status":"publish","type":"disclosure","link":"https:\/\/www.salk.edu\/de\/news-release\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\/","title":{"rendered":"Salk Professor Ronald Evans awarded $1.2 million by Larry L. Hillblom Foundation to study a new druggable pathway that could help treat diabetes"},"content":{"rendered":"

LA JOLLA\u2014Professor Ronald Evans<\/a> will receive $1.2 million over four years as part of a Network Grant from the Larry L. Hillblom Foundation to examine a molecular pathway that regulates blood sugar and fat independent of insulin. The research will advance our understanding of type 2 diabetes and could lead to the development of new therapies for treating the disease. Other members of the team include Professors Jin Zhang and Alan Saltiel from the University of California San Diego.<\/p>\n

\"Ronald
Ronald Evans
Klicken Sie hier<\/a> f\u00fcr ein hochaufl\u00f6sendes Bild.
Kredit: Salk Institut<\/figcaption><\/figure>\n

\u201cWe are very thankful to the Larry L. Hillblom Foundation for funding Ron\u2019s project about this molecular pathway that could be targeted to treat type 2 diabetes,\u201d says Salk President and Professor\u00a0Rusty Gage<\/a>. \u201cThis work represents an exciting new avenue of diabetes research with many possibilities for translation into the clinic.\u201d<\/p>\n

Recently, the Evans lab discovered<\/a> that a hormone called FGF1 regulates blood sugar (glucose) by inhibiting fat breakdown (lipolysis), and thus simultaneously lowers both blood glucose and fat. This effect is rapid and similar to how insulin works. While insulin acts through a regulatory switch called PDE3, Evans found that FGF1 uses a parallel pathway called PDE4. This finding is important as insulin action is greatly reduced in people with type 2 diabetes. The Evans study further shows that even when insulin action is blocked, FGF1 continues to control both lipolysis and blood glucose levels. Insulin resistance is considered to be a major problem and hard to control, so FGF1 represents a novel target for developing therapies for type 2 diabetes. Now, with funding from the Larry L. Hillblom Foundation, the group will examine the FGF1 pathway in more detail, explore where the pathway is located in the cell, and test how the pathway functions during different forms of diabetes.<\/p>\n

\u201cUnderstanding this glucose-regulating mechanism will provide fundamental insight into how blood glucose is maintained and could lead to the development of new treatments for diabetes,\u201d says Evans, director of the Gene Expression Laboratory and holder of the March of Dimes Chair in Molecular and Developmental Biology. \u201cWe are grateful to the Larry L. Hillblom Foundation for funding this important and impactful project.\u201d<\/p>\n

The Larry L. Hillblom Foundation supports medical research within the state of California and facilitates interaction between networks of researchers.<\/p>","protected":false},"featured_media":0,"template":"","faculty":[91],"disease-research":[123],"class_list":["post-33126","disclosure","type-disclosure","status-publish","hentry","faculty-ronald-evans","disease-research-metabolism-and-diabetes"],"acf":[],"yoast_head":"\nSalk Professor Ronald Evans awarded $1.2 million by Larry L. Hillblom Foundation to study a new druggable pathway that could help treat diabetes - Salk Institute for Biological Studies<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.salk.edu\/de\/news-release\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Salk Professor Ronald Evans awarded $1.2 million by Larry L. Hillblom Foundation to study a new druggable pathway that could help treat diabetes - Salk Institute for Biological Studies\" \/>\n<meta property=\"og:description\" content=\"LA JOLLA\u2014Professor Ronald Evans will receive $1.2 million over four years as part of a Network Grant from the Larry L. Hillblom Foundation to examine a molecular pathway that regulates blood sugar and fat independent of insulin. The research will advance our understanding of type 2 diabetes and could lead to the development of new therapies for treating the disease. Other members of the team include Professors Jin Zhang and Alan Saltiel from the University of California San Diego.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.salk.edu\/de\/news-release\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\/\" \/>\n<meta property=\"og:site_name\" content=\"Salk Institute for Biological Studies\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-11T16:19:24+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.salk.edu\/wp-content\/uploads\/2021\/12\/Ronald-Evans-1500-300x450.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\\\/\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\\\/\",\"name\":\"Salk Professor Ronald Evans awarded $1.2 million by Larry L. Hillblom Foundation to study a new druggable pathway that could help treat diabetes - Salk Institute for Biological Studies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Ronald-Evans-1500-300x450.jpg\",\"datePublished\":\"2022-01-06T08:00:02+00:00\",\"dateModified\":\"2022-01-11T16:19:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\\\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\\\/#primaryimage\",\"url\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Ronald-Evans-1500-300x450.jpg\",\"contentUrl\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Ronald-Evans-1500-300x450.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.salk.edu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Salk Professor Ronald Evans awarded $1.2 million by Larry L. Hillblom Foundation to study a new druggable pathway that could help treat diabetes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#website\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/\",\"name\":\"Salk Institute for Biological Studies\",\"description\":\"The Power of Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.salk.edu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#organization\",\"name\":\"Salk Institute for Biological Studies\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/salk_logo_696.jpg\",\"contentUrl\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/salk_logo_696.jpg\",\"width\":696,\"height\":696,\"caption\":\"Salk Institute for Biological Studies\"},\"image\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Salk Professor Ronald Evans awarded $1.2 million by Larry L. Hillblom Foundation to study a new druggable pathway that could help treat diabetes - Salk Institute for Biological Studies","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.salk.edu\/de\/news-release\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\/","og_locale":"de_DE","og_type":"article","og_title":"Salk Professor Ronald Evans awarded $1.2 million by Larry L. Hillblom Foundation to study a new druggable pathway that could help treat diabetes - Salk Institute for Biological Studies","og_description":"LA JOLLA\u2014Professor Ronald Evans will receive $1.2 million over four years as part of a Network Grant from the Larry L. Hillblom Foundation to examine a molecular pathway that regulates blood sugar and fat independent of insulin. The research will advance our understanding of type 2 diabetes and could lead to the development of new therapies for treating the disease. Other members of the team include Professors Jin Zhang and Alan Saltiel from the University of California San Diego.","og_url":"https:\/\/www.salk.edu\/de\/news-release\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\/","og_site_name":"Salk Institute for Biological Studies","article_modified_time":"2022-01-11T16:19:24+00:00","og_image":[{"url":"http:\/\/www.salk.edu\/wp-content\/uploads\/2021\/12\/Ronald-Evans-1500-300x450.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.salk.edu\/news-release\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\/","url":"https:\/\/www.salk.edu\/news-release\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\/","name":"Salk Professor Ronald Evans awarded $1.2 million by Larry L. Hillblom Foundation to study a new druggable pathway that could help treat diabetes - Salk Institute for Biological Studies","isPartOf":{"@id":"https:\/\/www.salk.edu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.salk.edu\/news-release\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\/#primaryimage"},"image":{"@id":"https:\/\/www.salk.edu\/news-release\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\/#primaryimage"},"thumbnailUrl":"http:\/\/www.salk.edu\/wp-content\/uploads\/2021\/12\/Ronald-Evans-1500-300x450.jpg","datePublished":"2022-01-06T08:00:02+00:00","dateModified":"2022-01-11T16:19:24+00:00","breadcrumb":{"@id":"https:\/\/www.salk.edu\/news-release\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.salk.edu\/news-release\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\/"]}]},{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.salk.edu\/news-release\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\/#primaryimage","url":"http:\/\/www.salk.edu\/wp-content\/uploads\/2021\/12\/Ronald-Evans-1500-300x450.jpg","contentUrl":"http:\/\/www.salk.edu\/wp-content\/uploads\/2021\/12\/Ronald-Evans-1500-300x450.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.salk.edu\/news-release\/salk-professor-ronald-evans-awarded-1-2-million-by-larry-l-hillblom-foundation-to-study-a-new-druggable-pathway-that-could-help-treat-diabetes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.salk.edu\/"},{"@type":"ListItem","position":2,"name":"Salk Professor Ronald Evans awarded $1.2 million by Larry L. Hillblom Foundation to study a new druggable pathway that could help treat diabetes"}]},{"@type":"WebSite","@id":"https:\/\/www.salk.edu\/#website","url":"https:\/\/www.salk.edu\/","name":"Salk-Institut f\u00fcr biologische Studien","description":"Die Macht der Wissenschaft","publisher":{"@id":"https:\/\/www.salk.edu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.salk.edu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/www.salk.edu\/#organization","name":"Salk-Institut f\u00fcr biologische Studien","url":"https:\/\/www.salk.edu\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.salk.edu\/#\/schema\/logo\/image\/","url":"http:\/\/www.salk.edu\/wp-content\/uploads\/2023\/03\/salk_logo_696.jpg","contentUrl":"http:\/\/www.salk.edu\/wp-content\/uploads\/2023\/03\/salk_logo_696.jpg","width":696,"height":696,"caption":"Salk Institute for Biological Studies"},"image":{"@id":"https:\/\/www.salk.edu\/#\/schema\/logo\/image\/"}}]}},"ACF":{"gallery":false,"paper_url":"","journal_title":"","paper_author_list":"","doi":"","paper_title":"","subhead":"","home_photo":"","listing_photo":"","legacy_boilerplate":[],"hide_boilerplate":[],"disable_date":false,"listing_excerpt":"","descriptive_blurb":"","has_journal_cover":false,"og_image_override":false},"_links":{"self":[{"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/disclosure\/33126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/disclosure"}],"about":[{"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/types\/disclosure"}],"version-history":[{"count":3,"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/disclosure\/33126\/revisions"}],"predecessor-version":[{"id":33259,"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/disclosure\/33126\/revisions\/33259"}],"wp:attachment":[{"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/media?parent=33126"}],"wp:term":[{"taxonomy":"faculty","embeddable":true,"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/faculty?post=33126"},{"taxonomy":"disease-research","embeddable":true,"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/disease-research?post=33126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}